DOCSLIB.ORG

Santen CEO Small Meeting

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Santen CEO Small Meeting Santen CEO Small Meeting Santen Pharmaceutical Co., Ltd. December 3, 2020 Copyright© 2020 Santen All rights reserved. 0 People with Eye Problems will Increase Further Population growth Visually impaired or blind Aging world Lifestyle change 2.2bn Environmental change Source： WHO World report on vision Copyright© 2020 Santen All rights reserved. 1 Ophthalmic Disease Landscape Stage 1 Stage 2 Stage 3 Stage 4 Africa China/Southeast Asia Japan/Western ③Wellness Myopia/ Ptosis ②Treatment of diseases and conditions that do NOT lead to vision loss Dry eye ①Treatment of diseases and conditions Trachoma/ that can cause vision loss Cataract/ Infections AMD Glaucoma Copyright© 2020 Santen All rights reserved. 2 Ophthalmic Disease and Drugs Market Retinitis Glaucoma Myopia （aged 5～19） Pigmentosa China：20mil. China：120mil. Worldwide：1.9mil.*3 Number of Japan：5mil. Asia：54mil. Japan：18.7/100K.*4 Patients*1 Market size （by value*2) Atropine formulation is No fundamental treatment or Drugs commercialized in some effective drugs to control the Market countries. disease progression x12 DE-127 jCell +α （Licensed from jCyte） China Japan Regional and Business Growth Led by Ecosystem Development and New Modality *1: 2020/Decision Resources, LLC. All right reserved. Reproduction, distribution, transmission or publication is prohibited. Reprinted with permission. *2: Copyright © 2020 IQVIA. IQVIA MIDAS 2019.1Q-4Q; Santen analysis based on IQVIA data. Reprinted with permission. *3 Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40. *4: Japanese Ophthalmological Society Copyright© 2020 Santen All rights reserved. 3 Santen Business Model Sustainable growth enabled by our specialized knowledge with external expertise and technology (1) Ophthalmology (2) Wellness (3) Inclusion Competitiveness as a specialized company Copyright© 2020 Santen All rights reserved. 4 Expanding Solutions in Ophthalmology Expansion of portfolio through active partnerships Digital Device Small Molecules New Modality Check-up Support ophthalmologists’ Glaucoma Diagnosis Digital training treatment support Follow-up device Gene therapy Device Enhancement Expansion of Treatment pharmaceutical (Reimbursement) commercialization of core business business Glaucoma device ROCK inhibitor Cell therapy IOL Treatment Approach to Myopia progression (Out of Pocket) myopia Ptosis reduction for children Wellness Reprinted from JPM conference material in January 2021. Copyright© 2020 Santen All rights reserved. 5 Growth Scenario Image over Mid-to-Long Term by Regions EMEA US ・Steady growth enhanced by glaucoma ・Ready to enter into the market through and new products business the launch of DE-128 and the acquisition ・Functioning as a global hub of Eyevance ・Aim to swiftly turn profitable through inorganic growth including products from As is To be outside partners As is To be Japan ・Minimize the impact from patent expiration by adding new products and maintain our presence As is To be China Asia ・Possible impact in a short-term, but ・Developed countries or regions: Maintain continuous growth will be expected steady growth by new product launch based on the population growth and ・Developing countries or regions : Further ecosystem development expand by establishing ecosystem ・Enhance products portfolio As is To be As is To be Copyright© 2020 Santen All rights reserved. 6 Appendix Copyright© 2020 Santen All rights reserved. 7 VBP*1 Impact on Cravit in China • Cravit was listed for VBP*1 • Short-term impact on sales revenues and profits Market structure of Levofloxacin0.5%（volume）*2 Private Hospital, Public Hospitals Pharmacies, and Market Other Market （approx. 60%） （approx. 40%） Market not Market affected by VBP affected by VBP *1: Value-Based Purchasing: Government assurances on purchase volume for the successful bidders. 80% 20% *2: Estimated by Santen Copyright© 2020 Santen All rights reserved. 8 Copyright© 2020 Santen All rights reserved. 9.
Load more

Recommended publications
  • The Simplified Trachoma Grading System, Amended Anthony W Solomon,A Amir B Kello,B Mathieu Bangert,A Sheila K West,C Hugh R Taylor,D Rabebe Tekeraoie & Allen Fosterf
    PolicyPolicy & practice & practice The simplified trachoma grading system, amended Anthony W Solomon,a Amir B Kello,b Mathieu Bangert,a Sheila K West,c Hugh R Taylor,d Rabebe Tekeraoie & Allen Fosterf Abstract A simplified grading system for trachoma was published by the World Health Organization (WHO) in 1987. Intended for use by non-specialist personnel working at community level, the system includes five signs, each of which can be present or absent in any eye: (i) trachomatous trichiasis; (ii) corneal opacity; (iii) trachomatous inflammation—follicular; (iv) trachomatous inflammation—intense; and (v) trachomatous scarring. Though neither perfectly sensitive nor perfectly specific for trachoma, these signs have been essential tools for identifying populations that need interventions to eliminate trachoma as a public health problem. In 2018, at WHO’s 4th global scientific meeting on trachoma, the definition of one of the signs, trachomatous trichiasis, was amended to exclude trichiasis that affects only the lower eyelid. This paper presents the amended system, updates its presentation, offers notes on its use and identifies areas of ongoing debate. Introduction (ii) corneal opacity; (iii) trachomatous inflammation—fol- licular; (iv) trachomatous inflammation—intense; and (v) tra- Trachoma is the most important infectious cause of blindness.1 chomatous scarring.19 Trachomatous inflammation—follicular Repeated conjunctival infection2 with particular strains of and trachomatous inflammation—intense are signs of active Chlamydia trachomatis3–5
    [Show full text]
  • World Report on Vision Infographic
    World report on vision The Facts Projected number of people estimated to have age related macular degeneration and glaucoma, 2020–2030. 243.4 million 195.6 million Everyone, if they live long enough, will experience at least one eye condition in their lifetime. Age related macular degeneration (any) Cataract surgery US$ 6.9 billion 95.4 million Refractive error 76 million US$ 7.4 billion Glaucoma 2020 2030 US$14.3 billion (is the investment) needed globally to treat existing Eye conditions are projected to unaddressed cases of refractive error and cataract. increase due to a variety of factors, including ageing population, lifestyle and NCDs. At least 2.2 billion people live with a vision impairment In at least 1 billion of these cases, vision impairment low- and middle- high-income regions could have been prevented income regions or has yet to be addressed Unaddressed distance vision impairment in many low- and middle- income regions is 4x higher than in high- income regions. Unaddressed refractive error (123.7 million) Cataract (65.2 million) Glaucoma (6.9 million) Corneal opacities (4.2 million) Diabetic Retinopathy (3 million) Trachoma (2 million) Unaddressed presbyopia (826 million) Eye conditions The problem Some eye conditions do not typically cause vision impairment, but others can. Common eye conditions that do not typically cause vision impairment Eyelid Conjunctivitis Dry eye Eyelid Conjunctivitis Dry eye Availability inflammation Accessibility Cyst or Stye Benign growth SubconjunctivalSubconjunctival in thethe eyeeye haemorrhagehaemorrhage Acceptability Common eye conditions that can cause vision impairment Eye care services are poorly integrated into health systems. The availability, accessibility and acceptability of eye Cataract Corneal opacity GlaucomaGlaucoma care services have an influence on eye conditions and vision impairment.
    [Show full text]
  • Piloting the Treatment of Retinopathy in India Diabetic Retinopathy and Retinopathy of Prematurity
    Piloting the Treatment of Retinopathy in India Diabetic Retinopathy and Retinopathy of Prematurity Report of an Independent External Evaluation Amaltas Piloting the Treatment of Retinopathy in India Diabetic Retinopathy and Retinopathy of Prematurity Amaltas July 2019 Acknowledgements This report provides an independent, external evaluation of a large programme of work on retinopathy funded by the Queen Elizabeth Diamond Jubilee Trust Fund with additional funding from the Helmsley Trust Fund. We gratefully acknowledge the support from LSHTM and PHFI. Dr. GVS Murthy, Dr. Clare Gilbert, Dr. Rajan Shukla and Dr. Tripura Batchu extended every support to the evaluators. The wonderful images are the work of photographer Rajesh Pande. Work on the programme was helmed by the Indian Institute of Public Health, Hyderabad, a centre of the Public Health Foundation of India, and the London School of Hygiene and Tropical Medicine, United Kingdom. The programme itself was a collaborative effort of many government and non government organisations and partners in India. This report has been prepared by Amaltas Consulting Private Limited, India. Amaltas (www.amaltas.asia) is a Delhi based organization with a mission to work within the broad scope of development to provide high quality consulting and research in support of accelerating improvements in the lives of people. The report was written by Dr. Suneeta Singh and Shivanshi Kapoor, Amaltas with support from Dr. Deepak Gupta, Consultant. TABLE OF CONTENTS Acronyms List of Figures List of Tables Executive
    [Show full text]
  • Guidelines for Universal Eye Screening in Newborns Including RETINOPATHY of Prematurity
    GUIDELINES FOR UNIVERSAL EYE SCREENING IN NEWBORNS INCLUDING RETINOPATHY OF PREMATURITY RASHTRIYA BAL SWASthYA KARYAKRAM Ministry of Health & Family Welfare Government of India June 2017 MESSAGE The Ministry of Health & Family Welfare, Government of India, under the National Health Mission launched the Rashtriya Bal Swasthya Karyakram (RBSK), an innovative and ambitious initiative, which envisages Child Health Screening and Early Intervention Services. The main focus of the RBSK program is to improve the quality of life of our children from the time of birth till 18 years through timely screening and early management of 4 ‘D’s namely Defects at birth, Development delays including disability, childhood Deficiencies and Diseases. To provide a healthy start to our newborns, RBSK screening begins at birth at delivery points through comprehensive screening of all newborns for various defects including eye and vision related problems. Some of these problems are present at birth like congenital cataract and some may present later like Retinopathy of prematurity which is found especially in preterm children and if missed, can lead to complete blindness. Early Newborn Eye examination is an integral part of RBSK comprehensive screening which would prevent childhood blindness and reduce visual and scholastic disabilities among children. Universal newborn eye screening at delivery points and at SNCUs provides a unique opportunity to identify and manage significant eye diseases in babies who would otherwise appear healthy to their parents. I wish that State and UTs would benefit from the ‘Guidelines for Universal Eye Screening in Newborns including Retinopathy of Prematurity’ and in supporting our future generation by providing them with disease free eyes and good quality vision to help them in their overall growth including scholastic achievement.
    [Show full text]
  • A Study of Prevalence of Dry Eye in Relation to Trachoma
    Original Research Article DOI: 10.18231/2395-1451.2017.0084 A study of prevalence of dry eye in relation to trachoma Dipak B. Patel1,*, Jyotindra N. Brahmbhatta2, Hemal V. Jasani3, Aditya P. Desai4, Parin K. Mehta5 1Professor, 4,5Resident Doctor, SBKS Medical Institute & Research Centre, Vadodara, Gujarat, 2Professor, CU Shah Medical College, Surendranagar, Gujarat, 3Cataract & Refractive Surgery, Dept. Ophthalmology, Netradeep Eye Hospital, Rajkot, Gujarat *Corresponding Author: Email: [email protected] Abstract Introduction: Dry eye disease is a multifactorial disorder of the tear film due to tear deficiency or excessive tear evaporation, which causes damage to the ocular surface leading to tear film instability and is associated with visual disturbances and symptoms of ocular discomfort. The prevalence of dry eye ranging from 5 to 35% Worldwide, while in India it is 29.25% based on OSDI data. Trachoma is the leading cause of infectious blindness worldwide. Destructive nature of trachoma causes dry eye in its chronic course. Materials and Methods: Total 100 patients were included in the cross-sectional study in the duration of one-year duration from February 2010 to February 2011 at Dhiraj General Hospital. They were subjected to slit-lamp biomicroscopy, Schirmer’s test I and TBUT. Prevalence of trachoma in diagnosed cases of dry eye was also studied. Results: Prevalence of dry eye during 2010-11 was 17.77%. Amongst them, the prevalence of trachoma was 5%. Mean age of patients was 44.7±14.09 years. Discussion: Dry eye is leading cause of ocular discomfort in OPD patients. Prevalence of dry eye increases with age.
    [Show full text]
  • Loss of Vision and Hearing
    Chapter 50 Loss of Vision and Hearing Joseph Cook, Kevin D. Frick, Rob Baltussen, Serge Resnikoff, Andrew Smith, Jeffrey Mecaskey, and Peter Kilima Although the loss of vision and hearing has multiple causes, account uncorrected refractive errors, but this change has not and the burden of these diseases is complex, three major points yet been approved. emerge from the outset: The major causes of adult-onset blindness are cataract (47.8 percent), glaucoma (12.3 percent), macular degeneration • Impairments of the essential senses of vision and hearing (8.7 percent), diabetic retinopathy (4.8 percent), trachoma contribute to early demise and are important causes of mor- (3.6 percent), and onchocerciasis (0.8 percent). Uncorrected bidity for individuals who are blind or deaf. refractive errors are also a major cause of morbidity related to • Cost-effective interventions are available to address several vision, but this type of disability is not included in the global causes of these burdens now. burden of disease by definition. It has been estimated to be on • The number of cost-effectiveness analyses of interventions the order of 15 percent of the total blind population and could to preserve hearing or vision in developing countries is quite add 50 percent to the low-vision population. However, there limited. are no published data to do more than speculate. The major causes of childhood vision loss have marked Table 50.1 summarizes the conditions causing the sensory regional variations. They include vitamin A deficiency (xeroph- deficits, the proposed interventions and sites of delivery, and thalmia) and ophthalmia neonatorum in low-income coun- the cost and effectiveness of these interventions to the extent of tries, retinopathy of prematurity and hereditary conditions in current knowledge.
    [Show full text]
  • Visual Impairment Age-Related Macular
    VISUAL IMPAIRMENT AGE-RELATED MACULAR DEGENERATION Macular degeneration is a medical condition predominantly found in young children in which the center of the inner lining of the eye, known as the macula area of the retina, suffers thickening, atrophy, and in some cases, watering. This can result in loss of side vision, which entails inability to see coarse details, to read, or to recognize faces. According to the American Academy of Ophthalmology, it is the leading cause of central vision loss (blindness) in the United States today for those under the age of twenty years. Although some macular dystrophies that affect younger individuals are sometimes referred to as macular degeneration, the term generally refers to age-related macular degeneration (AMD or ARMD). Age-related macular degeneration begins with characteristic yellow deposits in the macula (central area of the retina which provides detailed central vision, called fovea) called drusen between the retinal pigment epithelium and the underlying choroid. Most people with these early changes (referred to as age-related maculopathy) have good vision. People with drusen can go on to develop advanced AMD. The risk is considerably higher when the drusen are large and numerous and associated with disturbance in the pigmented cell layer under the macula. Recent research suggests that large and soft drusen are related to elevated cholesterol deposits and may respond to cholesterol lowering agents or the Rheo Procedure. Advanced AMD, which is responsible for profound vision loss, has two forms: dry and wet. Central geographic atrophy, the dry form of advanced AMD, results from atrophy to the retinal pigment epithelial layer below the retina, which causes vision loss through loss of photoreceptors (rods and cones) in the central part of the eye.
    [Show full text]
  • Retinal Detachment in Southwest Ethiopia: a Hospital Based Prospective Study
    Retinal Detachment in Southwest Ethiopia: A Hospital Based Prospective Study Tsedeke Asaminew, Yeshigeta Gelaw*, Sisay Bekele, Berhan Solomon Department of Ophthalmology, College of Public Health and Medical Sciences, Jimma University, Jimma, Ethiopia Abstract Purpose: The incidence of retinal detachment in Blacks is generally considered to be low though there are few supporting studies in Africa. This study, thus, aimed at describing the clinical profile of patients with retinal detachment in Southwest Ethiopia. Methods: A hospital-based study was done on all consecutive retinal detachment patients who presented to Jimma University Hospital over six months period. A semi-structured questionnaire was used to collect patients’ sociodemographic characteristics and clinical history. Comprehensive anterior and posterior segment eye examinations were done and risk factors were sought for. Statistical tests were considered significant if P < 0.05. Results: A total of 94 eyes of 80 patients (1.5%) had retinal detachment (RD) and about 69% of patients were symptomatic for over a month before presentation. The mean age was 41.4 years (SD ±16.5). Fourteen patients (17.5%) had bilateral RD. At presentation, 61 eyes (64.9%) were blind from RD and 11 (13.8%) patients were bilaterally blind from RD. Rhegmatogenous RD was seen in 55 eyes (58.5%) and tractional RD in 22 eyes (23.4%). The most common risk factors were ocular trauma (32 eyes, 34.0%), myopia (23 eyes, 24.5%), posterior uveitis (13 eyes, 13.8%) and diabetic retinopathy (9 eyes, 9.6%). Most retinal breaks (25 eyes, 43.1%) were superotemporal and horse-shoe tear was the most common (19 eyes, 20.2%).
    [Show full text]
  • The Definition and Classification of Dry Eye Disease
    DEWS Definition and Classification The Definition and Classification of Dry Eye Disease: Report of the Definition and Classification Subcommittee of the International Dry E y e W ork Shop (2 0 0 7 ) ABSTRACT The aim of the DEWS Definition and Classifica- I. INTRODUCTION tion Subcommittee was to provide a contemporary definition he Definition and Classification Subcommittee of dry eye disease, supported within a comprehensive clas- reviewed previous definitions and classification sification framework. A new definition of dry eye was devel- T schemes for dry eye, as well as the current clinical oped to reflect current understanding of the disease, and the and basic science literature that has increased and clarified committee recommended a three-part classification system. knowledge of the factors that characteriz e and contribute to The first part is etiopathogenic and illustrates the multiple dry eye. Based on its findings, the Subcommittee presents causes of dry eye. The second is mechanistic and shows how herein an updated definition of dry eye and classifications each cause of dry eye may act through a common pathway. based on etiology, mechanisms, and severity of disease. It is stressed that any form of dry eye can interact with and exacerbate other forms of dry eye, as part of a vicious circle. II. GOALS OF THE DEFINITION AND Finally, a scheme is presented, based on the severity of the CLASSIFICATION SUBCOMMITTEE dry eye disease, which is expected to provide a rational basis The goals of the DEWS Definition and Classification for therapy. These guidelines are not intended to override the Subcommittee were to develop a contemporary definition of clinical assessment and judgment of an expert clinician in dry eye disease and to develop a three-part classification of individual cases, but they should prove helpful in the conduct dry eye, based on etiology, mechanisms, and disease stage.
    [Show full text]
  • Is Household Air Pollution a Risk Factor for Eye Disease?
    Int. J. Environ. Res. Public Health 2013, 10, 5378-5398; doi:10.3390/ijerph10115378 OPEN ACCESS International Journal of Environmental Research and Public Health ISSN 1660-4601 www.mdpi.com/journal/ijerph Review Is Household Air Pollution a Risk Factor for Eye Disease? Sheila K. West 1,*, Michael N. Bates 2, Jennifer S. Lee 1, Debra A. Schaumberg 3,4,5, David J. Lee 6, Heather Adair-Rohani 7, Dong Feng Chen 5 and Houmam Araj 8 1 Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, MD 21287, USA; E-Mail: [email protected] 2 School of Public Health, Divisions of Epidemiology and Environmental Health Sciences, University of California, Berkeley, CA 94720, USA; E-Mail: [email protected] 3 John A. Moran Eye Center, Department of Ophthalmology and Visual Sciences, University of Utah School of Medicine, Salt lake City, UT 84132, USA; E-Mail: [email protected] 4 Department of Epidemiology, Harvard School of Public Health, Boston, MA 02215, USA 5 Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA; E-Mail: [email protected] 6 Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, FL 33101, USA; E-Mail: [email protected] 7 World Health Organization, Geneva CH-1211, Switzerland; E-Mail: [email protected] 8 National Eye Institute, Bethesda, MD 20892, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-410-955-2606; Fax: +1-410-955-0096. Received: 19 September 2013; in revised form: 18 October 2013 / Accepted: 19 October 2013 / Published: 25 October 2013 Abstract: In developing countries, household air pollution (HAP) resulting from the inefficient burning of coal and biomass (wood, charcoal, animal dung and crop residues) for cooking and heating has been linked to a number of negative health outcomes, mostly notably respiratory diseases and cancers.
    [Show full text]
  • The Trachoma Story
    Questions about the cause, the effect, the diagnosis, the infectivity, the clinical pattern, the prevention, and the treatment of trachoma are answered by an ophthalmologist from his experience and from the literature. The Trachoma Story By ARTHUR A. SINISCAL, M.D. T lIE IMPORTAN-CE of trIachoma "as a well kniowni in the civilizations of the four great sourice of hlumtiani suii ngeiiiir, as a cause of river valleys-the Ilwaicr Ho anid the Yanig(tze blinidniess, anid as a niatioinal economnic loss over Kian(r, the IJiduts anid Ganges, the Euphlrates large tracts of the world's surface is seconid to aiid Tigris, anid the :Nile-many centuries be- nlonle amllonicg the diseases of the eye, or inideed, fore Chlrist. It was recogniized anid treated in monll (liseases of all kinids." aInIcienit Egyp)t, Greece, aind Romile, as well as Tlhus Sir Stewar-t Duke-Elder, a distin- in cotuntries of Bliblical famiie. The Moslem guislhed4 B3ritislh oplhthalnmologist, assessed tra- coniquests p)robably led to its spread to Europe elhomia in a textbook published in 1934 (1). As as early as tlle eightlh cenitury (4), anid, unii- late as 1950, it was estimllated that 15 to 20 per- dooubtedly, Napoleon's campaigni to Egypt in cenit of the world populationi suffered fromi this 1798-1802 was responisible in large measure for disease (2). its dispersion aiiiongt the Euiropeanis () Throughout the wvorld, traclhoiniatologists, B3elieved to lhavle been ilitlodiUCe(l inito the oplhtlhalmuologists, sociologists, ptublic hiealtl Uniited States duIIrinig coloniial tiimes by Euri-o- workers, aid otliers are strlivingr earnestly to im- pean inuniiigrianits (6), the disease was spread prove the liealtlh anid socioecoiomic coii(litionls thromughout a cenitral belt reaching fr-omii the Al- of those afflicted witlh trachlomlla.
    [Show full text]
  • Acquired Etiologies of Lacrimal System Obstructions
    5 Acquired Etiologies of Lacrimal System Obstructions Daniel P. Schaefer Acquired obstructions of the lacrimal excretory outfl ow system will produce the symptoms of epiphora, mucopurulent discharge, pain, dacryocystitis, and even cellulitis, prompting the patient to seek the ophthalmologist for evaluation and treatment. Impaired tear outfl ow may be functional, structural, or both. The causes may be primary – those resulting from infl ammation of unknown causes that lead to occlusive fi brosis—or secondary, resulting from infections, infl amma- tion, trauma, malignancies, toxicity, or mechanical causes. Secondary acquired dacryostenosis and obstruction may result from many causes, both common and obscure. Occasionally, the precise pathogenesis of nasolacrimal duct obstruction will, despite years of investigations, be elusive. To properly evaluate and appropriately treat the patient, the ophthal- mologist must have knowledge and comprehension of the lacrimal anatomy, the lacrimal apparatus, pathophysiology, ocular and nasal relationships, ophthalmic and systemic disease process, as well as the topical and systemic medications that can affect the nasolacrimal duct system. One must be able to assess if the cause is secondary to outfl ow anomalies, hypersecretion or refl ex secretion, pseudoepiphora, eyelid malposition abnormalities, trichiasis, foreign bodies and conjunctival concretions, keratitis, tear fi lm defi ciencies or instability, dry eye syn- dromes, ocular surface abnormalities, irritation or tumors affecting the trigeminal nerve, allergy, medications, or environmental factors. Abnormalities of the lacrimal pump function can result from involu- tional changes, eyelid laxity, facial nerve paralysis, or fl oppy eyelid syndrome, all of which displace the punctum from the lacrimal lake. If the cause is secondary to obstruction of the nasolacrimal duct system, the ophthalmologist must be able to determine where the anomaly is and what the cause is, in order to provide the best treatment possible for the patient.
    [Show full text]